Akihisa Sawada

2.7k total citations
71 papers, 1.5k citations indexed

About

Akihisa Sawada is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Akihisa Sawada has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Hematology and 21 papers in Immunology. Recurrent topics in Akihisa Sawada's work include Viral-associated cancers and disorders (26 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Immune Cell Function and Interaction (16 papers). Akihisa Sawada is often cited by papers focused on Viral-associated cancers and disorders (26 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Immune Cell Function and Interaction (16 papers). Akihisa Sawada collaborates with scholars based in Japan, United States and United Kingdom. Akihisa Sawada's co-authors include Masami Inoue, Keisei Kawa, Sadao Tokimasa, Ji Yoo Kim, Yoshihiro Takihara, Junichi Hara, Hideaki Ohta, Hiroshi Kimura, Yoshinori Ito and Koichi Ohshima and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Akihisa Sawada

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihisa Sawada Japan 19 691 506 499 360 344 71 1.5k
Karen P. Mann United States 21 752 1.1× 318 0.6× 241 0.5× 233 0.6× 656 1.9× 46 1.5k
N. M. Wulffraat Netherlands 17 418 0.6× 677 1.3× 586 1.2× 755 2.1× 120 0.3× 28 2.3k
Toshihiko Imamura Japan 25 338 0.5× 433 0.9× 657 1.3× 506 1.4× 138 0.4× 139 1.9k
George Carrum United States 17 1.0k 1.5× 714 1.4× 322 0.6× 232 0.6× 439 1.3× 53 1.6k
Benjamin Joachim Schmiedel Germany 21 488 0.7× 995 2.0× 172 0.3× 603 1.7× 93 0.3× 44 1.7k
Koichi Oshima Japan 17 261 0.4× 333 0.7× 164 0.3× 357 1.0× 142 0.4× 77 1.1k
Giorgio Inghirami United States 16 401 0.6× 640 1.3× 102 0.2× 231 0.6× 308 0.9× 28 1.3k
W Vos Netherlands 23 753 1.1× 416 0.8× 83 0.2× 330 0.9× 720 2.1× 48 1.4k
Jean‐Philippe Jais France 5 256 0.4× 758 1.5× 123 0.2× 322 0.9× 240 0.7× 5 1.3k
Ellen G. van Lochem Netherlands 16 201 0.3× 490 1.0× 178 0.4× 156 0.4× 213 0.6× 27 1.1k

Countries citing papers authored by Akihisa Sawada

Since Specialization
Citations

This map shows the geographic impact of Akihisa Sawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihisa Sawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihisa Sawada more than expected).

Fields of papers citing papers by Akihisa Sawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihisa Sawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihisa Sawada. The network helps show where Akihisa Sawada may publish in the future.

Co-authorship network of co-authors of Akihisa Sawada

This figure shows the co-authorship network connecting the top 25 collaborators of Akihisa Sawada. A scholar is included among the top collaborators of Akihisa Sawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihisa Sawada. Akihisa Sawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakata, Kayo, Toshitaka Morishima, Yoshihiro Kuwabara, et al.. (2024). Prevalence of survivors of childhood cancer based on a population‐based cancer registry in Osaka, Japan. International Journal of Cancer. 155(5). 839–848.
2.
Yamamoto, Masahide, Masataka Ishimura, Hirokazu Kanegane, et al.. (2024). JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. PubMed. 2(1). 100053–100053.
3.
Osone, Shinya, Nobuyuki Yamamoto, Koji Suzuki, et al.. (2022). Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan. International Journal of Clinical Oncology. 28(2). 331–340.
4.
Sawada, Akihisa, et al.. (2021). Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children. International Journal of Hematology. 115(2). 269–277.
5.
Imadome, Ken‐Ichi, Tohru Kobayashi, Masahide Yamamoto, et al.. (2020). Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Advances. 4(13). 2918–2926. 53 indexed citations
6.
7.
Arai, Ayako, Ken‐Ichi Imadome, Tohru Kobayashi, et al.. (2018). A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies. Blood. 132(Supplement 1). 1631–1631. 1 indexed citations
8.
Okuno, Yusuke, Takayuki Murata, Yoshitaka Sato, et al.. (2017). Genetic Background of Chronic Active Epstein-Barr Virus Disease. Blood. 130. 1468–1468. 4 indexed citations
9.
Kanda, Yoshinobu, Junya Kanda, Yoshiko Atsuta, et al.. (2014). Changes in the Clinical Impact of High-Risk Human Leukocyte Antigen Allele Mismatch Combinations on the Outcome of Unrelated Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(4). 526–535. 13 indexed citations
10.
11.
Kimura, Hiroshi, Yoshinori Ito, Shinji Kawabe, et al.. (2011). EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 119(3). 673–686. 304 indexed citations
12.
Yamada, K, Masahiro Yasui, Akihisa Sawada, et al.. (2011). Severe persistent bone marrow failure following therapy with 2‐chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain. Pediatric Blood & Cancer. 58(2). 300–302. 16 indexed citations
13.
Sawada, Akihisa, Masahiro Yasui, Osamu Kondo, et al.. (2011). Multiplex polymerase chain reaction for six herpesviruses after hematopoietic stem cell transplantation. Pediatrics International. 53(6). 1010–1017. 6 indexed citations
14.
Sawada, Akihisa, Emiko Sato, Ji Yoo Kim, et al.. (2006). NK-cell repertoire is feasible for diagnosing Epstein–Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect. American Journal of Hematology. 81(8). 576–581. 11 indexed citations
15.
Yumura‐Yagi, Keiko, Masaki Inoue, Naoki Sakata, et al.. (2005). Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience. Bone Marrow Transplantation. 36(4). 307–313. 6 indexed citations
16.
Sawada, Akihisa, Yoshihiro Takihara, Ji Yoo Kim, et al.. (2003). A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. Journal of Clinical Investigation. 112(11). 1707–1713. 111 indexed citations
17.
Tokimasa, Sadao, Hideaki Ohta, Akihisa Sawada, et al.. (2001). Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage. Experimental Hematology. 29(1). 93–103. 50 indexed citations
18.
Yumura‐Yagi, Keiko, Masami Inoue, Naoaki Sakata, et al.. (2000). Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.. PubMed. 71(3). 278–82. 3 indexed citations
19.
Kawai, Masanobu, Akihisa Sawada, Sadao Tokimasa, et al.. (2000). Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha. Bone Marrow Transplantation. 26(6). 681–683. 9 indexed citations
20.
Sawada, Akihisa, et al.. (1986). [A case of biloma after acute cholecystitis].. PubMed. 31(9). 1057–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen P. Mann Breakdown of academic impact, for papers by N. M. Wulffraat Breakdown of academic impact, for papers by Toshihiko Imamura Breakdown of academic impact, for papers by George Carrum Breakdown of academic impact, for papers by Benjamin Joachim Schmiedel Breakdown of academic impact, for papers by Koichi Oshima Breakdown of academic impact, for papers by Giorgio Inghirami Breakdown of academic impact, for papers by W Vos Breakdown of academic impact, for papers by Jean‐Philippe Jais Breakdown of academic impact, for papers by Ellen G. van Lochem
Rankless by CCL
2026